Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CD3EAP |
| Upstream (Parents) |
|---|
| (<<) MAD2L1 → CD3EAP |
| (<<) MTHFD2 → CD3EAP |
| (<<) UBE2S → CD3EAP |
| (<<) SLC25A6 → CD3EAP |
| (<<) TAF1D → CD3EAP |
| Downstream (Children) |
|---|
| CD3EAP → LTF (>>) |
| CD3EAP → PIWIL1 (>>) |
| CD3EAP → KCNV2 (>>) |
| CD3EAP → SSX2B///SSX2 (>>) |
| CD3EAP → LOC650293///UNC93B4///UNC93B2///LOC442381///OR7E125P///OR7E37P///OR7E87P (>>) |
| CD3EAP → DEC1 (>>) |
| CD3EAP → CAMK2B (>>) |
| CD3EAP → MSX1 (>>) |
| CD3EAP → ATG10 (>>) |
| CD3EAP → TNXB (>>) |
| CD3EAP → RPS2 (>>) |
| CD3EAP → RPS9 (>>) |
| CD3EAP → NPM3 (>>) |
| CD3EAP → ZNF473 (>>) |
| CD3EAP → HOMER1 (>>) |
